Search
for
Sort by
Research 421–450 of 1000+
- The role of dutasteride in the treatment of benign prostatic obstruction and related conditions
- Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
- The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
- Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
- Menstrual Irregularity in Women with Acromegaly
- Protective effects of melatonin against metabolic and reproductive disturbances in polycystic ovary syndrome in rats
- Polycystic ovary syndrome (PCOS)
- Shorter CAG repeats in the androgen receptor gene may enhance hyperandrogenicity in polycystic ovary syndrome
- Women's midlife health Reframing menopause
- Urinary 5-ene-steroid excretion in non-classical congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase deficiency (NC-3BHSD)
- Depression, higher level of tension induction, and impaired coping strategies in response to stress in women with PCOS correlate with clinical and laboratory indices of hyperandrogenism and not with central obesity and insulin resistance
- Androgen excess: a hallmark of polycystic ovary syndrome
- Kennedy's disease and partial androgen insensitivity syndrome. Report of 4 cases and literature review
- Androgens in women
- Understanding polycystic ovary syndrome
- Plasma Diaphanous Related Formin 1 Levels Are Associated with Altered Glucose Metabolism and Insulin Resistance in Patients with Polycystic Ovary Syndrome: A Case Control Study
- Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities
- Influence of Genotype and Hyperandrogenism on Sexual Function in Women With Congenital Adrenal Hyperplasia
- The effect of alfacalcidiol and metformin on metabolic disturbances in women with polycystic ovary syndrome
- Association of Gly972Arg variant of insulin receptor subtrate-1 and Gly1057Asp variant of insulin receptor subtrate-2 with polycystic ovary syndrome in the Chinese population
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
- Endothelial Dysfunction in PCOS: Role of Obesity and Adipose Hormones
- Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria
- Established risk factors for coronary heart disease are unrelated to androgen-induced baldness in female-to-male transsexuals
- Elevated Ghrelin Plasma Levels in Patients with Polycystic Ovary Syndrome
- Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome
- Androgen receptor gene CAG repeat polymorphism in women with polycystic ovary syndrome
- SLE and Serum Complement: Causative, Concomitant or Coincidental?
- Role of insulin resistance and diet in acne
- Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?